Inhibiting the inflammatory response in joint sepsis
Purpose: We created a rabbit model of infectious arthritis to test the effects of WRC-0470 (2-cyclohexylmethylidenehydarazinoadenosine), an adenosine analogue, and rolipram, a type IV phosphodiesterase inhibitor, on intra-articular white blood cell recruitment. Type of Study: Randomized trial involv...
Gespeichert in:
Veröffentlicht in: | Arthroscopy 2001-03, Vol.17 (3), p.311-315 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose: We created a rabbit model of infectious arthritis to test the effects of WRC-0470 (2-cyclohexylmethylidenehydarazinoadenosine), an adenosine analogue, and rolipram, a type IV phosphodiesterase inhibitor, on intra-articular white blood cell recruitment. Type of Study: Randomized trial involving mature rabbits. Methods: Intra-articular injections ranging from 0 to 2,000 ng of Escherichia coli lipopolysaccharide (LPS) were tested as the infectious stimulus. The optimal LPS amount was determined based on synovial fluid analysis for white blood cell counts. A separate cohort of rabbits then received various intravenous concentrations of either rolipram, WRC-0470, or a combination of the 2 medications. Synovial fluid aspirations after a 6-hour incubation were analyzed for white blood cell counts. Results: Intra-articular injections of 200 ng of LPS reproducibly generated an inflammatory response of 4,000 cells/mL of synovial fluid, establishing the use of this dose of LPS for our septic arthritis model. Following infusions of 10 μg/kg/min, the average white blood cell count dropped to 800 cells/mL for WRC-0470 (P |
---|---|
ISSN: | 0749-8063 1526-3231 |
DOI: | 10.1053/jars.2001.21492 |